OUR TEAM

Nickey Shah | Managing Director

Divyata Choudhary | Principal of Engagement

Divyata Choudhary is a fourth-year studying Economics and Cognitive Science at the University of Chicago. She joined EC in the fall of her second year and has led engagements with a Blackstone portfolio company and Easterseals. She has also consulted for Formula 1, Best Buddies and the Alzheimer’s Association. As Principal of Engagement, she is responsible for alumni engagement, developing relationships with recruiters and prospective clients, and supporting the professional development of EC members.

Outside of EC, Divyata is a member of the business fraternity Alpha Kappa Psi. She worked as a Hedging Summer Intern at Riverside Risk Advisors, where she gained exposure to derivatives advisory and risk management. This past summer, she worked as a Summer Analyst at StepStone Group, supporting infrastructure investment.

Joyce Huang | Principal of Growth & Operations

Joyce Huang is a third-year student at the University of Chicago studying Economics and Art History. She joined EC in the fall of her first year and has since consulted for Uber, the Girl Scouts, and Instacart. She led engagements with Teach for America and the American Red Cross. As Principal of Growth & Operations, Joyce is responsible for directing Eckhart’s new member recruitment process. Additionally, she also oversees daily operations and consultant feedback for the club. This past summer, Joyce worked as a Summer Analyst at a middle-market private equity firm.

Kelly Liu | Principal of Strategy

Kelly Liu is a fourth-year student at the University of Chicago studying Economics and Philosophy. Since joining Eckhart in the fall of her second year, she has consulted on projects for Formula 1 and Sotheby’s and most recently led engagements with Blackstone and the American Red Cross. As Principal of Strategy, Kelly leads internal professional training, defines project scopes, and ensures high-quality execution across client engagements. She has previously interned at a Fortune 100 pharmaceutical company and spent this past summer as an analyst on BlackRock’s private equity team.